Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nkarta, Inc. - Common Stock
(NQ:
NKTX
)
2.860
+0.220 (+8.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nkarta, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
June 12, 2026
From
Equity Insider
Via
GlobeNewswire
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
June 08, 2026
From
Biotech Insider
Via
GlobeNewswire
Nkarta (NASDAQ:NKTX) Q1 2026 Narrower Loss Beats Estimates as Autoimmune Trial Advances
↗
May 12, 2026
Via
Chartmill
Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
May 12, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
April 15, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta to Participate in Needham Virtual Healthcare Conference
April 09, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
March 25, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta to Participate in March Investor Conferences
February 27, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta to Participate in Evercore Healthcare Conference
December 02, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights
November 10, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta to Participate in November Investor Conferences
October 30, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
October 22, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
August 28, 2025
Via
Benzinga
Nkarta Posts Narrower Loss in Q2
↗
August 13, 2025
Via
The Motley Fool
Topics
Intellectual Property
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights
August 12, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
June 06, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space
↗
May 15, 2025
Nkarta posts a smaller Q1 loss than expected and maintains strong cash reserves while analysts debate its trial strategy and market position.
Via
Benzinga
This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
↗
May 15, 2025
Via
Benzinga
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
May 14, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Top movers in Thursday's session
↗
March 27, 2025
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Top stock movements in today's session.
↗
March 27, 2025
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 27, 2025
Via
Benzinga
Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday?
↗
March 27, 2025
Nkarta restructures to extend its cash runway into 2029, with upcoming NKX019 clinical data readouts in H2 2025. Analysts maintain Buy ratings.
Via
Benzinga
Which stocks are gapping on Thursday?
↗
March 27, 2025
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
March 26, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
December 05, 2024
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
November 07, 2024
From
Nkarta, Inc.
Via
GlobeNewswire
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
↗
October 08, 2024
Via
Benzinga
Why Nkarta Stock Is Soaring Today
↗
August 14, 2024
One analyst is now more bullish about this clinical-stage biotech stock.
Via
The Motley Fool
UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday
↗
August 14, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
